Business Context and Reporting Period
This Form 8-K filing by WellPoint, Inc. (now Elevance Health, Inc.) covers the period ending March 7, 2008, with the earliest event reported on March 3, 2008. The report details corporate governance actions regarding executive compensation established by the Compensation Committee of the Board of Directors.
Key Financial Metrics
The filing does not provide consolidated revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to executive compensation and stock pricing:
- Stock Price: The fair market value of WellPoint's common stock on March 3, 2008, was $70.80.
- Executive Compensation (2008):
- Angela F. Braly: Salary of $1,144,000; 270,849 stock options; 33,850 restricted stock units (RSUs); Annual Incentive Plan target of 130% of salary.
- Wayne S. DeVeydt: Salary of $636,000; 72,809 stock options; 29,100 RSUs; Annual Incentive Plan target of 85% of salary.
Material Changes
The filing reports the establishment of 2008 compensation packages for two executive officers. No material changes to the company's financial position, operations, or prior period results are disclosed in this specific report.
Guidance, Outlook, and Risks
Performance Metrics and Vesting Conditions:
- Stock Options: Vest in six equal semi-annual installments over three years beginning September 3, 2008.
- Restricted Stock Units (RSUs): Vesting is contingent upon the company's Return on Equity (ROE) for 2008 exceeding the ROE for 2007, after funding the RSU grants.
- Angela F. Braly: All 33,850 units vest in three equal annual installments starting March 3, 2009, subject to the ROE condition.
- Wayne S. DeVeydt: 9,100 units vest in three equal annual installments starting March 3, 2009, subject to the ROE condition. The remaining 20,000 units vest 50% on March 3, 2010, and 25% each on March 3, 2011 and 2012, subject to the ROE condition.
- Annual Incentive Plan: Performance measures include adjusted diluted Earnings Per Share (90%), Member Health Index (5%), and Service Excellence (5%). Payouts range from 0% to 200% of target based on performance, with individual adjustments capped to ensure aggregate awards do not exceed the total calculated without individual adjustments.
Investor Verification Checklist
- Verify the company's 2007 Return on Equity (ROE) to assess the baseline for 2008 RSU vesting conditions.
- Confirm the total number of shares outstanding to calculate the dilution impact of the 343,658 new stock options granted.
- Review the company's 2008 Annual Report to determine if the ROE target was met and if the RSUs vested as scheduled.
- Check subsequent filings for any changes to the executive compensation structure or the departure of the named officers.